Haleon plc (HLN)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
- Ticker
- HLN
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- 52-week range
- $8.38 - $11.28
Valuation
- Share price
- $9.14 (close of Nov 6, 2026)
- P/E (TTM)
- 18.26x
- Price to book
- 1.85x
- Price to free cash flow
- 13.19x
Price performance
| Period | Change |
|---|---|
| 1 day | -0.11% |
| 5 days | +5.54% |
| 1 month | +3.04% |
| 3 months | -8.87% |
| 6 months | -0.98% |
| Year to date | -9.59% |
| 1 year | -2.87% |
| 3 years | +12.70% |
| All time | +25.21% |
Short interest
- As of
- Oct 15, 2026
- Short % of float
- 0.42%
- Shares short
- 18.54M
- Days to cover
- 1.08
- Change since prior report
- -25.36%
- Source
- FINRA consolidated short interest
Members of Congress who disclosed HLN trades
Lisa McClain · Val Hoyle · Josh Gottheimer
Super investors holding HLN
Dodge & Cox (Dodge & Cox Funds) · Bill Nygren (Harris Associates LP) · First Eagle Investment (First Eagle Investment Management, LLC) · Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates) · Tweedy Browne (Tweedy Browne Company LLC) · Kahn Brothers (Kahn Brothers Group)
Profitability and growth
- Return on equity
- 10.11%
- Return on invested capital
- 7.74%
- Return on assets
- 5.11%
- Return on capital employed
- 8.71%
- Gross margin
- 64.19%
- Net margin
- 15.11%
- EBITDA margin
- 25.13%
- Revenue growth
- -1.81%
- Net income growth
- 15.60%
- Free cash flow growth
- 12.73%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 7.58%
- Current ratio
- 0.92x
- Net debt to EBITDA
- 2.54x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Shares outstanding
- 4.49B
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 64.19% | 15.11% | 10.11% | 7.74% |
| 2024-12-31 | 60.75% | 12.84% | 8.89% | 6.73% |
| 2023-12-31 | 59.70% | 9.28% | 6.27% | 5.65% |
| 2022-12-31 | 60.57% | 9.76% | 6.44% | 4.93% |
| 2021-12-31 | 62.34% | 14.56% | 5.25% | 5.42% |
| 2020-12-31 | 59.75% | 11.58% | 4.37% | - |
| 2019-12-31 | 56.63% | 7.72% | 2.39% | - |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-07-30 | Jun 2026 | - |
| 2025-02-27 | Dec 2024 | - |
| 2024-10-31 | Sep 2024 | - |
| 2024-08-01 | Jun 2024 | - |
| 2024-05-01 | Mar 2024 | - |
| 2024-02-29 | Dec 2023 | - |
| 2023-11-02 | Sep 2023 | - |
| 2023-08-02 | Jun 2023 | - |
Filings and sources
- Company website
- haleon.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Hims & Hers Health, Inc. (HIMS) · Viatris Inc (VTRS) · Zoetis Inc. (ZTS) · Teva Pharmaceutical Industries Ltd (TEVA) · McKesson Corp (MCK) · Cencora, Inc. (COR) · Cardinal Health Inc (CAH) · Henry Schein Inc (HSIC)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades